Magazine Article | January 9, 2018

Classifying Independent Contractors: 3 Things Pharma CEOs Should Know

Source: Life Science Leader

By Rebecca Cenni

Pharmaceutical companies abide by strict regulations and ensure compliance during drug development and manufacturing, but when it comes to regulations surrounding employment, it’s imperative to exercise the same level of care. Not unlike a clinical trial setback, misclassification of independent contractors (ICs) can have a substantial negative impact on the business. Here are three key IC considerations pharma execs should ensure are addressed by compliance efforts.